Live from the NIH registry
Studies recruiting near Laredo right now
Top 22 of 22 recruiting studies, sorted by proximity — each links to its official registry page
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: NRG Oncology
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
Phase 1, Phase 2
Interventional 92 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Aminex Therapeutics, Inc.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Oncology and Hematology of South Texas - 1165 — Laredo, Texas (4.1 mi)
· Sponsor: OncoC4, Inc.
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract
Age Related Cataracts
Phase 2
Interventional 40 participants sought
Valley Retina Institute P.A. — Laredo, Texas (4.1 mi)
· Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9901 — Laredo, Texas (4.1 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
Phase 1, Phase 2
Interventional 796 participants sought
Oncology and Hematology of South Texas, PA — Laredo, Texas (4.1 mi)
· Sponsor: DualityBio Inc.
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Aeres Clinical Research — Laredo, Texas (4.1 mi)
· Sponsor: Cleerly, Inc.
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Hypertension, Acute Severe Hypertension
Phase 2
Interventional 140 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Kardigan, Inc.
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Phase 3
Interventional 3,082 participants sought
Andres Garcia Zuniga, M.D., P.A. ( Site 3782) — Laredo, Texas (4.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Laguna Clinical Research Associates LLC ( Site 0068) — Laredo, Texas (4.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Colorectal Cancer, CRC (Colorectal Cancer)
Phase 2
Interventional 136 participants sought
NGM Clinical Study Site — Laredo, Texas (4.1 mi)
· Sponsor: NGM Biopharmaceuticals, Inc
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Cancer Weight Loss
Phase 2
Interventional 120 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Endevica Bio
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Laredo Medical Center — Laredo, Texas (4.1 mi)
· Sponsor: Stryker Instruments
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Laredo, Texas (4.1 mi)
· Sponsor: Alnylam Pharmaceuticals
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Phase 1, Phase 2
Interventional 52 participants sought
Doctors Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: SynDevRx, Inc.
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Advanced Spine Pain Solutions — Laredo, Texas (4.1 mi)
· Sponsor: Boston Scientific Corporation
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Laguna Clinical Research Associates, LLC — Laredo, Texas (4.1 mi)
· Sponsor: CSL Behring
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Local Institution - 0652 — Laredo, Texas (4.1 mi)
· Sponsor: Mirati Therapeutics Inc.
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Aeres Clinical Research — Laredo, Texas (4.1 mi)
· Sponsor: Novo Nordisk A/S
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: City of Hope Medical Center